Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
BLSM

Updated 10/6/2026, 1:28 PM ET.

BLSM

BlossomHill Therapeutics, Inc.

Buy$10,000,000

GORDON CARL L

Director

625,000 shat $16.00Filed Aug 12, 4:46 PM ETFiling
BLSM

BlossomHill Therapeutics, Inc.

Buy$10,000,000

ORBIMED ADVISORS LLC

Director

and 1 other

625,000 shat $16.00Filed Aug 12, 4:43 PM ETFiling
BLSM

BlossomHill Therapeutics, Inc.

Buy$96,000

Schmid John P.

Director

6,000 shat $16.00Filed Aug 10, 6:35 PM ETFiling
BLSM

BlossomHill Therapeutics, Inc.

Buy$5,000,000

Chen Bihua

Director, 10% owner

and 5 others

312,500 shat $16.00Filed Aug 10, 6:32 PM ETFiling
BLSM

BlossomHill Therapeutics, Inc.

Buy$11,200

Keyes Jason A

Chief Financial Officer

700 shat $16.00Filed Aug 10, 6:27 PM ETFiling
BLSM

BlossomHill Therapeutics, Inc.

Buy$74,700

Liptak Vincent Paul

General Counsel

4,700 shat $15.89Filed Aug 10, 6:26 PM ETFiling

Read from public SEC filings. Not financial advice.